Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

1.8K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

313
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313
Liver Physiology01:30

Liver Physiology

4.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.7K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How I manage cirrhosis in a busy outpatient clinic? The P.O.R.T.A.L.V.E.I.N. mnemonic.

The American journal of gastroenterology·2026
Same author

Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.

Gut microbes·2026
Same author

Correction to: Serum and Urinary Metabolomics Reflect the Early Stages of De Novo Metabolic Syndrome After Liver Transplant: A 2-Center Longitudinal Study.

Clinical and translational gastroenterology·2026
Same author

Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study.

Gastro hep advances·2026
Same author

Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence.

Alimentary pharmacology & therapeutics·2026
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026

Related Experiment Video

Updated: Mar 17, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K

Gut microbiome and liver disease.

Naga S Betrapally1, Patrick M Gillevet1, Jasmohan S Bajaj2

  • 1Microbiome Analysis Center, George Mason University, Manassas, Va.

Translational Research : the Journal of Laboratory and Clinical Medicine
|August 2, 2016
PubMed
Summary

Gut microbiota alterations significantly influence chronic liver diseases like cirrhosis. Understanding these changes is key to preventing severe complications and developing targeted therapies.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

15.0K

Related Experiment Videos

Last Updated: Mar 17, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

15.0K

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Immunology

Background:

  • Chronic liver diseases, including alcoholic and nonalcoholic fatty liver disease, are linked to significant gut microbiota dysbiosis.
  • Systemic inflammation, endotoxemia, and vasodilation, contributing to complications like spontaneous bacterial peritonitis and hepatic encephalopathy, may stem from altered gut environments.
  • The poor prognosis associated with these complications underscores the need for effective prevention and management strategies.

Purpose of the Study:

  • To explore the role of gut microbiota composition and function in the development and progression of chronic liver diseases.
  • To investigate the relationship between gut microbiota alterations and clinical outcomes in patients with liver cirrhosis.
  • To assess the potential of microbiota-targeted therapies for managing chronic liver conditions.

Main Methods:

  • Culture-independent analyses of microbial communities in stool, colonic mucosa, and saliva from human and animal models.
  • Correlation of microbial profiles with disease presence, severity, and clinical events.
  • Review of existing literature on the impact of various therapies on gut microbiota in liver disease.

Main Results:

  • Significant variations in the relative abundance and functional capacity of gut microbiota are associated with chronic liver disease and cirrhosis.
  • Specific microbial signatures correlate with the risk of developing severe complications.
  • Emerging evidence suggests that therapeutic interventions can modulate the gut microbiota, impacting disease prognosis.

Conclusions:

  • Gut microbiota plays a critical role in the pathogenesis and progression of chronic liver diseases.
  • Microbiota analysis offers a promising avenue for prognostication and the development of novel therapeutic strategies.
  • Targeted modulation of the gut microbiota holds potential for improving patient outcomes in liver cirrhosis and related conditions.